Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet Rich Plasma for Resistant Corneal Ulcers
NCT05515731Phase 4Completed
- Start
- Jan 2021
- Primary completion
- Dec 2021
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of autologous platelet-rich plasma eye drops in corneal ulcer. Started Jan 2021; status: completed.
02
Drugs
autologous platelet-rich plasma eye drops
03
Conditions
corneal ulcer
Beyond the preview
Go deeper on NCT05515731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05515731.